Suggested Topics within your search.
Suggested Topics within your search.
- methods 5
- Therapeutic use 4
- therapeutic use 4
- Anesthesia 3
- Anesthetics 3
- therapy 3
- Anesthesiology 2
- Biochemistry 2
- Chemistry, Clinical 2
- Chemotherapy 2
- Cognitive Therapy 2
- Health and Fitness 2
- Pharmacology 2
- pharmacology 2
- Analgesia 1
- Analgesics 1
- Anti-Infective Agents 1
- Anti-infective agents 1
- Anxiety Disorders 1
- Child welfare 1
- Clinical Chemistry Tests 1
- Clinical chemistry 1
- Cognitive therapy 1
- Communicable diseases in children 1
- Congresses 1
- Cultural Diversity 1
- Custody of children 1
- Diarrhea, Infantile 1
- Diet therapy 1
- Diet therapy for infants 1
-
2241
-
2242
Brain Oscillations Elicited by the Cold Pressor Test: A Putative Index of Untreated Essential Hypertension
Published 2017-01-01Get full text
Article -
2243
Diet-derived urolithin A is produced by a dehydroxylase encoded by human gut Enterocloster species
Published 2025-01-01Get full text
Article -
2244
-
2245
Identification of Bexarotene as a PPARγ Antagonist with HDX
Published 2015-01-01Get full text
Article -
2246
Hypoglycemia Induced by Insulin as a Triggering Factor of Cognitive Deficit in Diabetic Children
Published 2014-01-01Get full text
Article -
2247
-
2248
SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylation
Published 2025-02-01“…SETD2 mutation promotes the epithelial-mesenchymal transition and is clinically associated with adverse outcomes highlighting a therapeutic need to develop targeted therapies against this dangerous mutation. …”
Get full text
Article -
2249
Oxidative stress promotes lipid-laden macrophage formation via CYP1B1
Published 2025-02-01“…CYP1B1 contributes to ROS-induced LLM formation and may serve as a therapeutic target for reducing LLM-induced lung damage.…”
Get full text
Article -
2250
-
2251
PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma
Published 2025-02-01“…This study points out lipid metabolism rewiring as a non-genetic resistance-causing mechanism in HNSCC that may be therapeutically targeted to overcome acquired resistance to anti-EGFR therapy.…”
Get full text
Article -
2252
-
2253
-
2254
-
2255
Ibrutinib disrupts blood-tumor barrier integrity and prolongs survival in rodent glioma model
Published 2024-04-01Get full text
Article -
2256
Agonistic anti-NKG2D antibody structure reveals unique stoichiometry and epitope compared to natural ligands
Published 2024-12-01“…This binding interaction, as compared to NKG2D natural ligands, suggests there may be unique mechanisms to engage this receptor while offering possible benefits when incorporated into an IgG-based therapeutic.…”
Get full text
Article -
2257
The Need for Inducing Tolerance in Vascularized Composite Allotransplantation
Published 2012-01-01Get full text
Article -
2258
-
2259
-
2260